We have a unique CRO profile providing unique and innovative dual expertise combining clinical research implementation with the development of customized IT applications specific to the pharmaceutical industry.
2017 WUHAN Convention on Innovative therapeutics for Cancer and Ageing diseases
Mrs Sylvie Kahn (VP Operations) and Mrs Virginie Droal (Clinical Project Manager) from PopsiCube-Fovea give a talk at the 2017 WUHAN Convention on Innovative therapeutics for Cancer and Ageing diseases conference in Wuhan (China).
During 4 days, this fifth edition proposed by IBBS will allow a wider number of Chinese and French participants from both academic and industrial sectors in the field of cancer and ageing associated diseases to:
- develop solid scientific and clinical exchanges on the most up to date knowlegde between academics, clinicians, biotechs and industrial players
- share innovative solutions from Bench to market to prevent or cure cancer and ageing associated diseases
- set-up one-to-one partnering meetings to favor innovative solution valorization
- educational sessions on cancer and ageing associated diseases and on research valorization.
It will be held in Wuhan, Hubei, on October 24-27, 2017 and co-organized by Institut Curie, Huazhong University of Science and Technology, The French anticancer center Léon Bérard, the Sino French Scholl of Oncology, the French Consulate in Wuhan, Popsicube-Fovea, MyPharmaCompany and many more…
Hoping to meet all of you in Wuhan, for sharing our common wish to defeat cancer and ageing associated diseases as soon as possible.
